From: Effect of bevacizumab combined with chemotherapy on SDF-1 and CXCR4 in epithelial ovarian cancer and its prognosis
Factor
β
SE
Wald
P
OR
95% CI
Chemotherapy regimen
1.158
2.369
0.000
0.001
1.253
0.430~13.268
Clinical staging
1.103
1.780
0.832
0.024
1.000
0.231~4.251
SDF-1
1.083
1.294
0.759
0.012
1.643
0.172~20.000
CXCR4
2.307
3.852
0.174
0.046
1.736
0.024~2.452